INSM Michael Alexander Smith sells $1.8M worth of shares
Jun 04, 2025, 4:35 AM
0.00%
What does INSM do
Insmed is a biopharmaceutical company based in Bridgewater, New Jersey, focusing on therapies for rare diseases, employing 912 staff. Its key products include ARIKAYCE, brensocatib, and TPIP for various lung diseases.
Michael Alexander Smith sold 26,327 shares of INSM on 30 May at $70.00 per share, worth a total of $1.8M. They now own 91,045 INSM shares, or a 27% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
